bepridil has been researched along with Anomalous Ventricular Excitation Syndrome in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Touboul, P | 1 |
| Atallah, G | 1 |
| Kirkorian, G | 1 |
| Lavaud, P | 1 |
| Kieny, JR | 1 |
| Mathieu, MP | 1 |
| Dellinger, A | 1 |
1 other study available for bepridil and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Electrophysiological action of bepridil on atrioventricular accessory pathways.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Bepridil; Female; Heart Conduction System; Humans; Male; | 1987 |